RDX-023

N/A

Report date: 2023/05/17 08:51:42

NME

Base Information

Drug NameRDX-023

Drug Alias NameRDX-023

ClassificationSmall molecules

Mechanisms of ActionBile acid receptor FXR agonists

TargetsBile acid receptor FXR

Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesArdelyx Inc

China Registration ClassN/A

Active CompaniesArdelyx Inc

Inactive CompaniesN/A

Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Inactive IndicationsN/A

ATC CodeN/A